Global study finds 250 genes linked to OCD
12 June, 2025Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after identifying 30 regions on the human genome associated with this debilitating condition.
Novel tool enables more precise gene therapy
10 June, 2025A novel gene editor dubbed 'evoCAST' helps solve the problem of how to add long stretches of DNA to defined locations in the human genome without creating unwanted modifications.
Genes influence when babies start walking
02 June, 2025Genetics accounts for about a quarter of the differences in when children take their first steps, suggesting that some children may naturally start walking earlier or later because of their genetic propensity.
World's first patient treated with personalised gene editing
20 May, 2025In what is being described as a historic medical breakthrough, an infant diagnosed with a rare genetic disorder has been treated with a customised CRISPR gene editing therapy.
Prenatal stress leaves a molecular mark on newborns
15 May, 2025An international study has uncovered how stress experienced during pregnancy can affect newborns at the molecular level — with significant differences between male and female babies.
Korea's Haenyeo show genetic adaptation to cold-water diving
14 May, 2025The Haenyeo, a group of all-female divers from the Korean island of Jeju, are renowned for their ability to dive in frigid waters without the aid of breathing equipment — even while pregnant.
Osteoarthritis study uncovers new genetic links, drug targets
08 May, 2025The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500 of which had never been reported before.
EpiCypher CUTANA meCUT&RUN and Multiomic CUT&RUN DNA methylation sequencing assays
29 April, 2025EpiCypher has announced CUTANA meCUT&RUN and Multiomic CUT&RUN — two novel DNA methylation sequencing technologies designed to advance the frontiers of genomic research and drug discovery.
Modifications in the placenta linked to psychiatric disorders
22 April, 2025Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders most strongly linked to DNA methylation in the placenta.
Colossal announces 'de-extinction' of the dire wolf
10 April, 2025Colossal Biosciences has announced what it describes as the rebirth of the dire wolf, which would make it the world's first successfully de-extincted animal.
Call for greater diversity in genomics research
25 March, 2025A gene variant common in Oceanian communities has been misclassified as a potential cause of heart disease, highlighting the risk of the current diversity gap in genomics research.
'Woolly mouse' created on the quest to bring back the mammoth
05 March, 2025By modifying seven genes simultaneously, Colossal created mice with a coat colour, texture and thickness reminiscent of the woolly mammoth's core phenotypes.
Genetic risk of schizophrenia impacts men and women differently
04 March, 2025Men tend to present different clinical symptoms from women, poorer premorbid functioning and earlier onset of the disease.
MGI DNBSEQ-E25 Flash AI-enhanced sequencer
27 February, 2025Built on self-luminescence technology and a CMOS-based flow cell, the next-generation sequencer has been designed to leverage AI-optimised protein engineering for enhanced signal intensity and precision.
MGI DNBSEQ-T1+ mid-throughput sequencer
27 February, 2025MGI's DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 h with Q40 accuracy.
